Sadness as an integral part of depression by Mouchet-Mages, Sabine & Baylé, Franck J.
espite their obvious clinical relevance,the terms
“sad”or “sadness”are not defined in some major psychi-
atric dictionaries, such as the Campbell Psychiatric
Dictionary
1 and the Lexicon of Psychiatry,Neurology and
the Neurosciences
2 or the French Academy of Medicine’s
Dictionary.
3This is even more surprising,given that sad-
ness (“tristis” in classical Latin) was commonly given a
psychological meaning in the ancient Latin world. In
Latin-based languages,the meaning was linked to melan-
cholia and sorrow later,during the 14th century.The term
was used to nickname Don Quixote the “knight of the sad
face,”in the 17th century.
4
From a medical historical perspective,sadness was described
in patients for a long time before the term depression was
introduced.For example,Hippocrates defined melancholia
as a state of persistent fear and sadness.In the middle of the
19th century, when the concept of depressive disorder
appeared,sadness was closely linked to motor retardation,
and sometimes delusions,both included in the depressive
syndrome.By the end of the 19th century,Kraepelin had
described several types of depression,corresponding to var-
ious states of motor and psychic retardation.Beginning with
Kraepelin,successive classifications have been developed,
so as to better identify depressive disorders, mainly in
dimensional ways.Beyond the symptomatic clusters that
nowadays define depression, the importance of the core
symptoms of depression,and in particular of sadness,could
be crucial from a clinical point of view.Its potential value as
a diagnostic marker of depression needs to be explored,as
well as its usefulness as a criterion for measuring the thera-
peutic effects of antidepressants.This review aims at criti-
cally exploring sadness,as a core symptom—an integral part
of depression,and proposes to describe its clinical aspects,
its links to neurovegetative symptoms,and the pertinence
of its use as a target for therapeutics.
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Sadness is considered by numerous authors to be a core
symptom of depression. Currently, many arguments exist
for its particular importance in depressed patients. Sadness
makes up part of the various definitions of the depressive
syndrome, even if its presence is not required for diagno-
sis. Furthermore, it is closely linked to the other depressive
symptoms, and has prognostic value, in particular for
remission. The recognition and measurement of sadness
seem important for therapeutic evaluation, in clinical stud-
ies, and in depressed patients at an individual level. This
paper presents a selective review of some of the various
aspects of sadness as an integral part of depression, and
an examination of its links with a disease which is a major
health concern. 
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and classifications of depression
Sadness is considered to be one of the core symptoms
of depression by most authors. Its clinical importance
for the depressive syndrome has been attested to by
various studies.Among the arguments for its clinical
value is the fact that sadness is present in an increasing
number of patients when depression grows in severity,
as Beck described in a study in 486 subjects, ranging
from nondepressed controls to severely ill patients
(Table I).
5
As described by Beck, sadness is present in a certain
number of healthy controls,who do not reach the crite-
ria for depressive disorders;on the other hand,in severe
depression, a low mood is present in only 94% of the
subjects, which implies that some severely depressed
patients do not experience sadness as part of their
depressive syndrome.The clinical reliability of sadness
for diagnosing depression could thus be challenged. In
developed countries,the medical services available and
the decrease in stigmatization should explain the fact
that a number of clinical cases of depression are diag-
nosed before the illness increases in severity. These
points should lead to describing and considering each
depressive disorder distinctly,using the clinical features
of their original description.
In the two main classification systems that are currently
used, sadness is one of the main symptoms of depres-
sion, but this is not enough for the diagnosis. In the
International Classification of Diseases,10th edition,or
ICD-10,
6 and in the Diagnostic and Statistical Manual of
Mental Disorders, 4th revision (DSM-IV, American
Psychiatric Association
7),whereas sadness is one of the
main depressive symptoms, the diagnosis of major
depression can be attributed without the presence of
sadness. Currently, the diagnosis of major depressive
episode is drawn from the presence of five of various
symptoms among nine (weight variation,insomnia,psy-
chomotor agitation or retardation, loss of energy, feel-
ings of worthlessness, diminished concentration, recur-
rent thoughts of death), which must include depressed
mood or lost of interest or pleasure in almost all activ-
ities.
7 This definition, while including sadness as one of
the main symptoms, also raises the possibility that
patients suffer from depressive episodes without being
sad.Furthermore,elderly patients can suffer from sub-
syndromal depression, which does not fulfill the com-
plete diagnostic criteria,even when antidepressant ther-
apies are clearly needed.
8 In those patients,sadness can
be absent from the clinical presentation.
Then,the question of the severity of depression is of par-
ticular clinical interest,to determine the potential impor-
tance of sadness for a patient,as well of the question of
its identification.One of the main depression evaluation
tools is the Hamilton Rating Scale for Depression
(HAM-D
9). Its various factorial analyses have consis-
tently identified “depressed mood” and “reduced work
and interest” to be the main symptoms of depression,
which is consistent with international classifications.
Scoring instructions have been published in agreement
with its author,
10 but not all versions have been approved
by him.Other tools have also been constructed,such as
the Beck Depression Inventory
11 and the Montgomery
and Asberg Depression Rating Scale (MADRS).
12 To
determine the clinical value of the various symptoms
assessed by these scales,a hierarchical pattern of depres-
sive symptoms has been identified with the use of the
Present State Examination (PSE
13),in a general popula-
tion study.The authors concluded that the prevalence of
the rarer symptoms such as guilty feelings, depression
worst in the morning, and suicide, were preceded by a
higher prevalence of the most common symptoms,such
as depressed mood,lack of energy,and worrying.
14 Such
hierarchical patterns have also been described using the
HAM-D
15:for the HAM-D 6-item version,the frequency
of depressive symptoms decreases in the following man-
ner: depressed mood, tiredness and pain, psychic anxi-
ety, guilt feelings, and psychomotor retardation. This
hierarchical pattern, with a higher prevalence of
depressed mood,confirms the clinical importance of sad-
ness in the diagnosis of depression. Furthermore, using
a neural network model on the results of the
Epidemiological Catchment Area study (ECA),a more
recent analysis
16 revealed that sadness was among the
symptoms with the greatest impact on the occurrence of
depression.
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Healthy Mild Moderate Severe 
controls depression depression depression
Low mood  16 72 94 94
(% subjects)
Table I. Frequency of low mood acording to the severity of depression.
Adapted from ref 5: Beck AT. Depression: Clinical, Experimental and
Theoretical Aspects. New York, NY: Harper & Row; 1967. Copyright ©
Harper and Row 1967Is sadness synonymous with depression?
As Beck described it,
1 sadness can be present in the
general population,without any diagnosis of depression.
Some epidemiological studies have reported the preva-
lence of depression in the general population, but only
a few have detailed depressive symptoms.Among them,
a relationship has been described between particular
life events and depressive symptoms
17 in the general
population. Sadness was more frequently associated
with deaths of loved ones and romantic breakups to be
at the origin of their dysphoric episode in patients
reporting an adverse event,whereas subjects for whom
no causality could be found reported a low mood less
frequently.
Another general population study, conducted in the
UK,
14 used the PSE to evaluate depressive symptoms.In
this study, depressed mood was found to be one of the
most frequent symptoms.Some limitations to this evalu-
ation are that the measurement of depressed mood was
based on a categorical scale (present/absent), which is
less precise than the HAM-D,where sadness is indicated
on a 5-point rating scale.This evaluation could not be
precise enough to discriminate between “normal”sad-
ness and depressed mood included in a depressive state.
The quality of sadness thus appears to be of importance;
this appears in the context of other tools.For example,in
the Newcastle Diagnostic Depression Scale,
18 patients are
asked whether their sadness is different from “normal”
response to stress or life events, so as to discriminate
between depressive and reactive states.
Apart from studies in the general healthy population,
sadness can be a comorbid symptom of various diseases,
which does not imply that it is part of a depressive
episode.For example,in Parkinson’s disease,25% of the
patients presented with depressed mood,
19 but very few
reached the full criteria for depression.However,in this
study,the authors concluded that even with a low mood,
patients were depressed and required an antidepressant
only in a few cases.
Nevertheless,this point is a great matter of debate,and
Horwitz and Wakefield argue that,while depressive dis-
order certainly exists and can be a devastating condition
warranting medical attention,the apparent epidemic in
fact reflects the way the psychiatric profession has under-
stood and reclassified normal human sadness as largely
an abnormal experience.They give strong support to this
thesis in a recently published book.
20
What is the impact of sadness on the 
clinical features of depression?
Some authors have investigated the clinical importance of
the presence or absence of sadness in depression.They
focused on the distinction between the presence or
absence of anhedonia and sadness,which are the two main
symptoms that must be present in international classifica-
tions to allow the diagnosis (DSM-IV,
8;ICD-10,
11).In par-
ticular,some authors addressed the question of whether
depressed individuals who denied low mood would con-
stitute a particular subgroup.
21 In this study in 902 patients
fulfilling the DSM-IV criteria for depressive episode,63
did not report low mood. They had briefer, less severe
episodes and reported less suicidal ideation than patients
with low mood.They also scored higher on four subscales
of the SF-36, indicating better health and functioning.
These results suggest that patients who deny low mood
could constitute a distinct subgroup;furthermore,the clin-
ical importance of sadness for depressed patients is under-
lined,with a prognostic value.A recent investigation was
conducted among 564 patients with major depression,in
order to evaluate clinical characteristics of the patients
with or without sadness.
22 Sadness was found to be signif-
icantly associated with major depressive disorder symp-
tom expression.In particular,sadness was associated with
higher rates of reactivity of mood,social impairment,social
withdrawal,physical complaints,and terminal insomnia.
By contrast,the absence of sadness was associated with
higher rates of diurnal mood variations and hypersomnia.
A statistical tendency for significance was found for the
desire to be dead;the authors suggest that clinicians should
carefully monitor patients presenting with sadness for
being at higher risk of suicide.
As sadness appears to be a major symptom of depression,
it has been postulated that sadness intensity could be used
to clinically discriminate subgroups of patients.Recently,
some authors used data from outpatients participating in
three large American multicenter clinical trials, for the
treatment of major depressive episode,in order to evalu-
ate clinical features of bipolar versus major depressive dis-
order.
23They report demographic but also clinical differ-
ences assessed with the HAM-D and MADRS scales;in
particular,fears were more common in patients with bipo-
lar disorders,whereas sadness,but also insomnia,intellec-
tual,somatic,respiratory and genitourinary complaints,
and depressed behavior were more frequent in unipolar
depression.By using a logistic regression model,86.9% of
Sadness in depression - Mouchet-Mages and Baylé Dialogues in Clinical Neuroscience - Vol 10 . No.3 . 2008
323the patients were correctly classified.Such clinical distinc-
tions could be useful to detect bipolar disorders, which
could be of importance for the patients’ outcome.
Another particular case is that of the elderly.Whereas the
prevalence of depression is independent of age,
24 a high
rate of depressive symptoms requiring treatments has
been reported,among which sadness can be described.
25
In clinical practice,the low prevalence of depression could
be due to the inadequacy of evaluation tools in the elderly,
with an underdetection of subthreshold depression,of high
prevalence in old age.
8This underreporting of depression
could also be due to alternative presentations of depres-
sion at older ages,as well as to poorly distinguish sadness
as a depressive symptom from “resignation due to age,”
which in turn is a common misconception.
26
Is sadness the cause or consequence of 
neurovegetative symptoms?
Neurovegetative symptoms are important components of
the depressive state.They include sleep disorders,appetite
modifications,and autonomic anxiety,consisting of car-
diovascular, respiratory, and genitourinary symptoms.
27
They differ from the HAM-D “general somatic” symp-
toms,which include tiredness,muscular tension,and pains,
and shares its phenomenology with the core symptoms of
depression.In the HAM-D,the neurovegetative symptoms
of affective disorders covering autonomic symptoms are
combined into a single somatic anxiety item.Some studies
have shown that benzodiazepines and β-blockers have a
specific effect on autonomic symptoms.
28 Furthermore,in
depressed patients,once these symptoms are alleviated,
these classes of drugs seem to induce sadness;more than
a causal relationship,this effect suggests that autonomic
symptoms could mask depressive disorders.
Some epidemiological arguments exist for a close rela-
tionship between vegetative symptoms and mood disor-
ders. One of the most studied symptoms, insomnia, has
been found to be closely linked to depression.For exam-
ple,Ford
29 found that subjects with complaints of persis-
tent insomnia were three times more likely to develop
depression within a 1-year interval than those without per-
sistent insomnia.In a longitudinal epidemiological study
of young adults,the association between sleep disturbance
and psychiatric disorders was cross-sectionally and
prospectively assessed.
30The gender-adjusted relative risk
for new onset of major depression during the follow-up
period was 4 in patients with a baseline history of insom-
nia and 2.9 for those with hypersomnia.The authors con-
clude that complaints of 2 weeks or more of insomnia
nearly every night might be a useful marker of subsequent
onset of major depression. Chang et al,
31 in a longer
prospective study of 34 years,reported that the relative
risk of clinical depression was double for men who
reported insomnia at baseline during medical school,an
effect that persisted for 30 years.However,it can not be
concluded whether depressive episodes could be “due”to
insomnia.It is also of note that depression without sleep
disorders or with hypersomnia is common,in particular in
seasonal affective disorders.
32
At the same time,most depressive disorders are charac-
terized by subjective sleep disturbances,and the regulation
of sleep is intricately linked to the same mechanisms that
are implicated in the pathophysiology of depression.
33 In
particular,serotoninergic and cholinergic pathways have
been implicated in the pathophysiology of both disorders.
34
Another striking example of the link between sleep and
depression is the antidepressant effect of therapeutic sleep
deprivation on depressive episodes.
35 However,even if bio-
logically linked,no arguments have been conclusive for
the causality of one symptom over the other.
Appetite, another vegetative symptom, is linked to
anorexia and weight loss, which are often described in
depression.High comorbidity has been described between
anorexia nervosa and depression. While some authors
have postulated that anorexia nervosa and bulimia may be
variant expressions of a primary mood disturbance,and
that the striking eating and weight-related symptoms are
secondary phenomena,
36 others suggested that the high
comorbidity observed could be due to a genetic liability
shared by the two diseases.
37 From a biological point of
view, some arguments exist for an implication of proin-
flammatory cytokines in depressed mood,and anhedonic
and anorexic responses.
38 In particular,some results sug-
gest that cytokines may contribute to the altered appetite
in major depression,through the hypothalamic-pituitary-
adrenal axis and leptin.However,the connection between
cytokines, appetite, and depression, and in particular of
sadness in depression, is at this time not well known.
Hyperphagia is another eating disturbance which has been
described in depression,and the relationships of hyper-
phagia,hypersomnia,and emotional dysregulation have
been studied in the context of the so-called “atypical
depression.”
39 For some authors,hypersomnolence might
be an adaptive homeostatic response that restores slow-
wave sleep during stress,and hyperphagia may be a com-
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L-tryptophan,increasing brain serotonin levels.However,
the determinants of hyperphagia should be examined in
more detail.
In other studies,a strong association between functional
somatic symptoms and depression was reported.In one of
them,
40 the association was equally strong for anxiety and
depression,and a stronger association was observed for
comorbid anxiety and depression.The association between
the number of somatic symptoms and the Hospital
Anxiety and Depression Scale total score was linear and
independent of gender.While reanalyzing the results of
the National Comorbidity Survey,Silverstein
41 concluded
that the gender difference generally described in depres-
sion may result from a difference in a specific subtype of
anxious somatic depression including fatigue,appetite,and
sleep disturbance.
Is sadness alleviation the appropriate 
therapeutic target in depression?
In randomized controlled trials of antidepressants,symp-
tom alleviation is evaluated with the use of validated clin-
ical assessments,such as the MADRS and HAM-D scales.
As sadness is evaluated with the use of these clinical tools,
some randomized antidepressant trials consider it as a
global indicator of symptomatic alleviation,and therefore
show it separately.However,the manner in which sadness
is evaluated in the scale is of great importance:for exam-
ple,in the PSE,it is scored on a categorical scale (present
or absent), in contrast to the HAM-D, where it is mea-
sured on a 5-point scale (from 0 to 4).
5 Furthermore,the
sensitivity of this evaluation needs to be challenged;this
has been done by some studies evaluating treatments with
several scales. For example, the results of a study of the
antidepressant venlafaxine used against placebo showed
depressed mood when assessed with the HAM-D to be
more sensitive than when assessed with the HAM-D17 or
the MADRS 10:a dose-response effect appeared as soon
as the first week,whereas it needed 3 weeks to be assessed
with the HAM-D and 4 with the MADRS.
42 One should
conclude then,that sadness as evaluated with the HAM-
D could be an efficient means of determining antidepres-
sant response, though it should be validated in clinical
studies.In fact,sound psychometric properties underlie
each construct of distinct questionnaires,and these con-
clusions should be considered with caution.
Most of the currently prescribed antidepressants have
been studied in controlled,designed clinical evaluations,
using one of the two main evaluation tools,the HAM-D
or MADRS.However,these scales would not be sufficient
to assess remission,as pointed out by the ACNP task force
on response and remission in major depressive disorders.
43
The authors postulate that remission implies that the signs
and symptoms of the illness must be absent or close to it,
with return to the day-to-day function that was typical to
the patient before the occurrence of depression.The Task
Force recommends that remission refer only to the nine
criterion domains of the DSM-IV diagnosis of depression.
Interestingly,they also specify that neither sad mood nor
loss of interest or pleasure should be present in the remit-
ted state,because the presence of sadness would be asso-
ciated with a worse prognosis.Their definition of remission
implies that rating scales used to assess remission would
assess the nine domains of interest in the DSM-IV, but
they also recommend not to use total scores with sever-
ity thresholds for the assessments,but rather to evaluate
the presence or absence of the criteria,in which sadness
takes an important part.They emphasize the limitations of
the MADRS and HAM-D scales, but at the same time
propose that a HAM-D total score ≤5 be used as a crite-
rion for remission,when researchers wish to evaluate this.
43
Conclusions
Sadness is a clinical main component of the depressive
syndrome, though its presence is neither sufficient nor
required for the diagnosis of depression.However,it is a
frequent clinical feature in the disease,and its clinical cor-
relates,such as suicide and level of daytime functioning,
are of importance for the patients.With this perspective,
some authors have decided to use it as a criterion for clin-
ical studies of antidepressant efficacy,even if its assessment
alone seems insufficient in comparison with standardized
evaluations.Though further studies assessing its sensitiv-
ity are strongly warranted,its use in clinical practice as a
therapeutic target appears to be justified.The prognostic
importance of its alleviation for remission has been par-
ticularly emphasized.
Given the heterogeneity of the depressive clinical pre-
sentation,one should not reduce depression to sadness;
at the same time it is justifiable to consider it as a clinical
core symptom of depression,and to properly assess and
treat it. ❏
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La tristeza como parte integral de la 
depresión
La tristeza es considerada por numerosos autores
como un síntoma central de la depresión.
Actualmente existen muchos argumentos para este
síntoma de especial importancia en los pacientes
depresivos. Aunque la tristeza forma parte de las
diversas definiciones del síndrome depresivo, no se
requiere de su presencia para el diagnóstico.
Además, está íntimamente vinculada a los otros sín-
tomas depresivos y tiene valor pronóstico, en espe-
cial para la remisión. El reconocimiento y la medi-
ción de la tristeza parecen ser importantes para la
evaluación terapéutica, tanto en los estudios clíni-
cos como en los pacientes depresivos en forma indi-
vidual. Este artículo presenta una revisión parcial de
algunos aspectos de la tristeza, como una parte
integral de la depresión, y examina sus vínculos con
una enfermedad que constituye una importante
preocupación en salud.
La tristesse : part déterminante de la 
depression
La tristesse est considérée comme un des symp-
tômes majeurs de la dépression par de nombreux
auteurs. Il existe en effet de nombreux arguments
cliniques permettant de soutenir son importance
très particulière chez les patients déprimés. Elle fait
partie des nombreuses définitions du trouble
dépressif. Si elle n’est pas une condition obligatoire
pour poser le diagnostic, son lien avec les autres
symptômes de la dépression et son importance pro-
nostique en font un symptôme clé. En conséquence
son évaluation est pertinente sur le plan thérapeu-
tique, tant au niveau individuel que collectif. Dans
cette revue, il est proposé de détailler de manière
critique certains des aspects cliniques de la tristesse,
en tant que part déterminante du syndrome
dépressif, et d’examiner ses liens avec la dépression,
trouble d’une importance majeure en termes de
santé publique.
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